ImageneBio Inc

Healthcare

NASDAQ:IMA · NASDAQ Global Market

Market Cap $64.18M Beta 0.72 P/E (TTM) -1.5

$6.00 +6.06%

+$0.35 today

52W Low $3.94High $18.00

Vol 0.03M · Avg 0.35M

EPS (TTM) -$4.02Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-62.69%

Period High

$17.90

Period Low

$4.55

Latest

$6.00

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Ovid Therapeutics Inc.

NASDAQ:OVID

$311.91M

Sutro Biopharma, Inc.

NASDAQ:STRO

$281.75M

Artiva Biotherapeutics, Inc.

NASDAQ:ARTV

$236.63M

Shattuck Labs, Inc.

NASDAQ:STTK

$234.01M

InflaRx N.V.

NASDAQ:IFRX

$131.10M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$126.56M

Kalaris Therapeutics Inc

NASDAQ:KLRS

$87.72M

Context Therapeutics Inc.

NASDAQ:CNTX

$56.41M

Metagenomi, Inc. Common Stock

MGX

$46.12M

Quince Therapeutics, Inc.

QNCX

$5.05M

What is the latest IMA filing?

The latest filing shown is 424B3 dated Jun 17, 2026.

How many recent filings does IMA have?

Intrinsic Alpha currently shows 20 recent filings for IMA.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.